ArticleCell and tissue research2025
Peroxisomes in the mouse ovary and their alterations during follicular development and oocyte maturation.
Article in Cell and tissue research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peroxisomes are the site of important metabolic pathways as they contain enzymes involved in the β-oxidation of fatty acids, the degradation of reactive oxygen species and the synthesis of ether-lipids and steroid hormone precursors. They are present in virtually all eukaryotic cells, yet they demonstrate considerable heterogeneity of number and protein composition. The presence of peroxisomes and concomitant activity of peroxisomal enzymes was previously documented in ovarian cells and it was suggested that peroxisomal oxidative stress management through catalase plays a pivotal role during oogenesis. In the present article, an exhaustive analysis is presented of the changes in peroxisome abundance during folliculogenesis in mouse oocytes. To this end, a quantitative assessment of the number of peroxisomes was conducted through morphometric analysis in the oocytes in follicular and oestrus cycle stages. Furthermore, a qualitative investigation was undertaken into the distribution of peroxisomal proteins involved in their biogenesis, membrane transport and lipid/hormone and reactive oxygen species metabolism in secondary and tertiary follicles. Given the metabolic connection between peroxisomes and mitochondria, the study was complemented with immunofluorescence stainings for reactive oxygen species and mitochondrial electron transport chain complexes and antioxidative enzymes. Our results confirmed the presence of peroxisomes in all follicular cells, including the oocyte. They further prove that peroxisomal abundance and protein composition are subject to variation depending on follicular and oestrus cycle stage and follicular cell type. Most strikingly, the study provided evidence of the near absence of catalase and of oxidative stress marker 8-oxo-2'-deoxyguanosine in the oocyte.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.